García Revilla, JuanHerrera Carmona, Antonio JoséMartínez de Pablos, RocíoVenero Recio, José Luis2023-05-182023-05-182022García Revilla, J., Herrera Carmona, A.J., Martínez de Pablos, R. y Venero Recio, J.L. (2022). Inflammatory Animal Models of Parkinson's Disease. Journal of Parkinson's Disease, 12, S165-S182. https://doi.org/10.3233/JPD-213138.1877-71711877-718Xhttps://hdl.handle.net/11441/146320Accumulating evidence suggests that microglia and peripheral immune cells may play determinant roles in the pathogenesis of Parkinson's disease (PD). Consequently, there is a need to take advantage of immune-related models of PD to study the potential contribution of microglia and peripheral immune cells to the degeneration of the nigrostriatal system and help develop potential therapies for PD. In this review, we have summarised the main PD immune models. From a historical perspective, we highlight first the main features of intranigral injections of different pro-inflammogens, including lipopolysaccharide (LPS), thrombin, neuromelanin, etc. The use of adenoviral vectors to promote microglia-specific overexpression of different molecules in the ventral mesencephalon, including -synuclein, IL-1β, and TNF, are also presented and briefly discussed. Finally, we summarise different models associated with peripheral inflammation whose contribution to the pathogenesis of neurodegenerative diseases is now an outstanding question. Illustrative examples included systemic LPS administration and dextran sulfate sodium-induced colitis in rodents.application/pdf18 p.engAtribución-NoComercial 4.0 Internacionalhttp://creativecommons.org/licenses/by-nc/4.0/Parkinson’s diseaseAnimal modelsMicrogliaInflammationSubstantia nigraLipopolysaccharideThrombinDextran sulfate sodiumAdenovirusinfo:eu-repo/semantics/articleinfo:eu-repo/semantics/openAccesshttps://doi.org/10.3233/JPD-213138